TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+20.4%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$815M
AUM Growth
+$815M
(+24%)
Cap. Flow
+$89.5M
Cap. Flow
% of AUM
10.98%
Top 10 Holdings %
Top 10 Hldgs %
43.07%
Holding
100
New
33
Increased
19
Reduced
13
Closed
5
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$20M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$14.2M |
| 3 |
Heron Therapeutics
HRTX
|
$13.2M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
$13.2M |
| 5 |
Insmed
INSM
|
$10.8M |
Top Sells
| 1 |
Veru
VERU
|
$40.7M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$30.6M |
| 3 |
Altimmune
ALT
|
$12.8M |
| 4 |
BioAtla
BCAB
|
$10.8M |
| 5 |
Inspirato
ISPO
|
$6M |
Sector Composition
| 1 | Healthcare | 96.03% |
| 2 | Communication Services | 1.61% |
| 3 | Consumer Discretionary | 0.82% |
| 4 | Consumer Staples | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AnaptysBio
ANAB
$569M
| $67.1M | 8.22% | 2,628,678 | – | – |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $42.3M | 5.19% | 280,000 | – | – |
|
|
BLUE
3
DELISTED
bluebird bio
BLUE
| $40.1M | 4.92% | 6,335,528 +424,841 | +7% | +$2.69M |
|
4
Tarsus Pharmaceuticals
TARS
$2.47B
| $35.8M | 4.39% | 2,089,856 +5,486 | +0.3% | +$93.9K |
|
|
5
Altimmune
ALT
$338M
| $33.2M | 4.07% | 2,600,450 -1,000,000 | -28% | -$12.8M |
|
|
ITCI
6
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $29.8M | 3.65% | 640,000 -60,000 | -9% | -$2.79M |
|
|
7
Heron Therapeutics
HRTX
$207M
| $28.9M | 3.54% | 6,840,000 +3,120,000 | +84% | +$13.2M |
|
8
Bio-Rad Laboratories Class A
BIO
$8.06B
| $26.7M | 3.27% | 64,000 +5,000 | +8% | +$2.09M |
|
9
KalVista Pharmaceuticals
KALV
$678M
| $26.1M | 3.2% | 1,800,000 | – | – |
|
|
ALBO
10
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $21.3M | 2.61% | 1,099,516 +399,516 | +57% | +$7.73M |
|
11
Rocket Pharmaceuticals
RCKT
$354M
| $20.2M | 2.48% | 1,265,900 | – | – |
|
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $20M | 2.45% | +100,000 | New | +$20M |
|
13
Immunocore
IMCR
$1.62B
| $19M | 2.33% | 405,600 +20,000 | +5% | +$939K |
|
14
Viridian Therapeutics
VRDN
$1.5B
| $18.1M | 2.22% | 882,925 +482,925 | +121% | +$9.9M |
|
15
iTeos Therapeutics
ITOS
| $17.9M | 2.19% | 937,500 | – | – |
|
|
16
BioAtla
BCAB
$26.7M
| $15.1M | 1.86% | 1,967,051 -1,405,949 | -42% | -$10.8M |
|
17
BioCryst Pharmaceuticals
BCRX
$1.74B
| $15.1M | 1.85% | 1,200,000 | – | – |
|
18
Relmada Therapeutics
RLMD
$37.2M
| $14.8M | 1.82% | 400,000 | – | – |
|
|
ONC
19
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $14.2M | 1.74% | +105,000 | New | +$14.2M |
|
20
Harmony Biosciences
HRMY
$2.12B
| $13.7M | 1.68% | 310,000 +10,000 | +3% | +$443K |
|
|
TWTR
21
DELISTED
Twitter, Inc.
TWTR
| $13.2M | 1.61% | +300,000 | New | +$13.2M |
|
|
22
Veru
VERU
$47.6M
| $12.7M | 1.55% | 1,100,000 -3,530,339 | -76% | -$40.7M |
|
|
23
Insmed
INSM
$28.8B
| $10.8M | 1.32% | +500,000 | New | +$10.8M |
|
24
Galapagos
GLPG
$2.07B
| $9.59M | 1.18% | 224,950 -25,050 | -10% | -$1.07M |
|
25
Mirum Pharmaceuticals
MIRM
$3.71B
| $9.46M | 1.16% | 450,000 +350,000 | +350% | +$7.35M |
|